Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study

Objective: In prostate specimens, chronic inflammatory infiltrate (CII) type IV has been detected, but its association with prostate cancer (PCa) is controversial. The aim of the present study is to investigate on associations of CII with PCa detection in patients undergoing prostate first biopsy se...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonio Benito Porcaro, Giovanni Novella, Matteo Balzarro, Guido Martignoni, Matteo Brunelli, Giovanni Cacciamani, Maria A. Cerruto, Walter Artibani
Format: Article
Language:English
Published: Elsevier 2015-10-01
Series:Asian Journal of Urology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214388215001022
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850234594565029888
author Antonio Benito Porcaro
Giovanni Novella
Matteo Balzarro
Guido Martignoni
Matteo Brunelli
Giovanni Cacciamani
Maria A. Cerruto
Walter Artibani
author_facet Antonio Benito Porcaro
Giovanni Novella
Matteo Balzarro
Guido Martignoni
Matteo Brunelli
Giovanni Cacciamani
Maria A. Cerruto
Walter Artibani
author_sort Antonio Benito Porcaro
collection DOAJ
description Objective: In prostate specimens, chronic inflammatory infiltrate (CII) type IV has been detected, but its association with prostate cancer (PCa) is controversial. The aim of the present study is to investigate on associations of CII with PCa detection in patients undergoing prostate first biopsy set. Methods: Ultrasound transrectal-guided biopsies by the transperineal approach were retrospectively evaluated in 441 consecutive patients. The study excluded patients who were in active surveillance, prostate specific antigen (PSA) ≥30 ng/mL, re-biopsies, incidental PCa after transurethral resection of the prostate (TURP), less than 14 cores or metastatic. Analysis of population and subpopulations (with or without PCa) was performed by statistical methods which included Mann–Whitney (U test), Kruskal–Wallis test, Chi-squared statistic, logistic regression. Multivariate logistic regression models predicting mean probability of PCa detection were established. Results: PCa detection rate was 46.03%. Age, PSA, prostate volume (PV), prostate intraepithelial neoplasia (PIN) and CII were the significant independent predictors of PCa detection. PV (OR = 0.934) and CII (OR = 0.192) were both negative independent predictors. CII was a significant negative independent predictor in multivariate logistic regression models predicting the mean probability of PCa detection by age, PSA and PV. The inverse association of CII with PCa does not necessary mean protection because of PSA confounding. Conclusion: In a population of patients undergoing prostate first biopsy set, CII was a strong negative independent predictor of PCa detection. CII type IV should be considered as an adjunctive parameter in re-biopsy or active surveillance protocols.
format Article
id doaj-art-c62fd339395f4b9d8bbe3b11d3cb2041
institution OA Journals
issn 2214-3882
language English
publishDate 2015-10-01
publisher Elsevier
record_format Article
series Asian Journal of Urology
spelling doaj-art-c62fd339395f4b9d8bbe3b11d3cb20412025-08-20T02:02:36ZengElsevierAsian Journal of Urology2214-38822015-10-012422423210.1016/j.ajur.2015.08.007Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort studyAntonio Benito Porcaro0Giovanni Novella1Matteo Balzarro2Guido Martignoni3Matteo Brunelli4Giovanni Cacciamani5Maria A. Cerruto6Walter Artibani7Urologic Clinic, University Hospital, Ospedale Policlinico, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyUrologic Clinic, University Hospital, Ospedale Policlinico, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyUrologic Clinic, University Hospital, Ospedale Policlinico, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyDepartment of Pathology, University Hospital, Ospedale Policlinico, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyDepartment of Pathology, University Hospital, Ospedale Policlinico, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyUrologic Clinic, University Hospital, Ospedale Policlinico, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyUrologic Clinic, University Hospital, Ospedale Policlinico, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyUrologic Clinic, University Hospital, Ospedale Policlinico, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyObjective: In prostate specimens, chronic inflammatory infiltrate (CII) type IV has been detected, but its association with prostate cancer (PCa) is controversial. The aim of the present study is to investigate on associations of CII with PCa detection in patients undergoing prostate first biopsy set. Methods: Ultrasound transrectal-guided biopsies by the transperineal approach were retrospectively evaluated in 441 consecutive patients. The study excluded patients who were in active surveillance, prostate specific antigen (PSA) ≥30 ng/mL, re-biopsies, incidental PCa after transurethral resection of the prostate (TURP), less than 14 cores or metastatic. Analysis of population and subpopulations (with or without PCa) was performed by statistical methods which included Mann–Whitney (U test), Kruskal–Wallis test, Chi-squared statistic, logistic regression. Multivariate logistic regression models predicting mean probability of PCa detection were established. Results: PCa detection rate was 46.03%. Age, PSA, prostate volume (PV), prostate intraepithelial neoplasia (PIN) and CII were the significant independent predictors of PCa detection. PV (OR = 0.934) and CII (OR = 0.192) were both negative independent predictors. CII was a significant negative independent predictor in multivariate logistic regression models predicting the mean probability of PCa detection by age, PSA and PV. The inverse association of CII with PCa does not necessary mean protection because of PSA confounding. Conclusion: In a population of patients undergoing prostate first biopsy set, CII was a strong negative independent predictor of PCa detection. CII type IV should be considered as an adjunctive parameter in re-biopsy or active surveillance protocols.http://www.sciencedirect.com/science/article/pii/S2214388215001022ProstateProstate cancerProstate specific antigenProstate biopsyChronic inflammationProstate volumeBiopsy Gleason score
spellingShingle Antonio Benito Porcaro
Giovanni Novella
Matteo Balzarro
Guido Martignoni
Matteo Brunelli
Giovanni Cacciamani
Maria A. Cerruto
Walter Artibani
Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study
Asian Journal of Urology
Prostate
Prostate cancer
Prostate specific antigen
Prostate biopsy
Chronic inflammation
Prostate volume
Biopsy Gleason score
title Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study
title_full Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study
title_fullStr Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study
title_full_unstemmed Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study
title_short Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study
title_sort prostate chronic inflammation type iv and prostate cancer risk in patients undergoing first biopsy set results of a large cohort study
topic Prostate
Prostate cancer
Prostate specific antigen
Prostate biopsy
Chronic inflammation
Prostate volume
Biopsy Gleason score
url http://www.sciencedirect.com/science/article/pii/S2214388215001022
work_keys_str_mv AT antoniobenitoporcaro prostatechronicinflammationtypeivandprostatecancerriskinpatientsundergoingfirstbiopsysetresultsofalargecohortstudy
AT giovanninovella prostatechronicinflammationtypeivandprostatecancerriskinpatientsundergoingfirstbiopsysetresultsofalargecohortstudy
AT matteobalzarro prostatechronicinflammationtypeivandprostatecancerriskinpatientsundergoingfirstbiopsysetresultsofalargecohortstudy
AT guidomartignoni prostatechronicinflammationtypeivandprostatecancerriskinpatientsundergoingfirstbiopsysetresultsofalargecohortstudy
AT matteobrunelli prostatechronicinflammationtypeivandprostatecancerriskinpatientsundergoingfirstbiopsysetresultsofalargecohortstudy
AT giovannicacciamani prostatechronicinflammationtypeivandprostatecancerriskinpatientsundergoingfirstbiopsysetresultsofalargecohortstudy
AT mariaacerruto prostatechronicinflammationtypeivandprostatecancerriskinpatientsundergoingfirstbiopsysetresultsofalargecohortstudy
AT walterartibani prostatechronicinflammationtypeivandprostatecancerriskinpatientsundergoingfirstbiopsysetresultsofalargecohortstudy